Today: 29 June 2026

Gemini Space Station (GEMI) Stock News Today: Prediction Markets License, Q3 Losses and 2026 Forecasts – December 11, 2025

Gemini Space Station (GEMI) Stock News Today: Prediction Markets License, Q3 Losses and 2026 Forecasts – December 11, 2025

Gemini Space Station shares surged as much as 13.7% after its affiliate won a U.S. license to run prediction markets, before retreating to $11.36 by early afternoon December 11. The stock remains about 60% below its $28 IPO price. CEO Tyler Winklevoss thanked President Trump and regulators for support. The new license allows Gemini to offer event-based contracts to U.S. customers.
11 December 2025
CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook

CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook

CapsoVision shares closed at $11.80 on December 10, up 32.7%, then surged to $18.04 in after-hours trading on heavy volume. The stock has gained 146% over the past month, with volatility and trading activity far above average. Pre-market quotes on December 11 show the price falling to $9.71, down 17.7% from the prior close. The surge follows renewed focus on the company's new finance chief, David Garcia.
Axon Enterprise (AXON) Stock Forecast: Tariff Hit, AI Ambitions and Wall Street’s 40% Upside View – December 11, 2025

Axon Enterprise (AXON) Stock Forecast: Tariff Hit, AI Ambitions and Wall Street’s 40% Upside View – December 11, 2025

Axon Enterprise shares closed at $568.39 on December 10, up 3.98% but still about 35–40% below their August peak near $886. The stock plunged after Q3 earnings, which showed 31% revenue growth but missed profit forecasts due to U.S. tariffs. Analysts’ 12-month price targets range from $815 to $845. Short selling has eased slightly as the stock stabilizes.
11 December 2025
Agape ATP (NASDAQ: ATPC) Stock Collapses to Penny Levels on Dec. 11, 2025: Price Crash, Dilution Fears and New Forecasts

Agape ATP (NASDAQ: ATPC) Stock Collapses to Penny Levels on Dec. 11, 2025: Price Crash, Dilution Fears and New Forecasts

Agape ATP Corporation shares plunged 95% on December 10, closing at $0.07 on heavy volume after trading as high as $1.13 intraday. By early pre-market December 11, the stock rebounded to $0.13–$0.17. Market cap hovered near $3.4 million. Multiple technical services shifted their outlook to “strong sell” or bearish, citing risk of further declines.
11 December 2025
Alphabet Stock in a ‘Code Red’ AI Arms Race: Why GOOG Is Dominating December 2025

Alphabet Stock in a ‘Code Red’ AI Arms Race: Why GOOG Is Dominating December 2025

Alphabet shares surged nearly 70% in 2025 as the company accelerated AI integration across its core businesses, driving mid-teens revenue growth in the third quarter. Analysts highlighted Alphabet as the top AI stock for 2026, citing strong margins and balance sheet. A major antitrust ruling in 2025 eased regulatory risk by blocking a Chrome spin-off but imposed new contract limits.
Lyft (LYFT) Stock Slides on Robotaxi Jitters Despite Analyst Upgrades – Latest News and 2026 Forecast

Lyft (LYFT) Stock Slides on Robotaxi Jitters Despite Analyst Upgrades – Latest News and 2026 Forecast

Lyft shares fell about 6.7% to $20.32 on December 10, capping a volatile year that saw the stock gain over 50% by early December before retreating. The drop followed reports of heavy trading volume and concerns over competition from Waymo and Tesla robotaxis, despite recent bullish analyst revisions.
HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

HeartBeam shares surged 92% to $1.55 on December 10 after the company won pivotal FDA clearance for its cable-free, at-home 12-lead ECG synthesis software. Trading volume topped 270 million shares, with market cap near $53 million by midday December 11. The clearance allows manual assessment of non-life-threatening arrhythmias in adults using synthesized ECGs outside clinics.
Synopsys Stock (SNPS) Jumps on Nvidia’s $2 Billion Bet, Q4 2025 Beat and Strong 2026 Outlook

Synopsys Stock (SNPS) Jumps on Nvidia’s $2 Billion Bet, Q4 2025 Beat and Strong 2026 Outlook

Synopsys shares rose about 2% to $476 in late-morning trading December 11 after reporting Q4 revenue of $2.26 billion, up 38% year over year and above estimates. Adjusted EPS reached $2.90, beating forecasts but down from $3.40 a year earlier. The stock remains 7% lower over the past year after a 36% plunge in September tied to China and Design IP concerns. Nvidia’s partnership and improved guidance have helped shares recover.
Cisco Stock Hits Record High on AI Boom: CSCO Forecast and Outlook After Its 2025 Rally

Cisco Stock Hits Record High on AI Boom: CSCO Forecast and Outlook After Its 2025 Rally

Cisco closed at a record $80.25 on December 10, surpassing its dot-com-era peak for the first time in 25 years. The stock is up about 33–36% year-to-date, with a market cap near $320 billion and a trailing P/E of 30. Recent earnings beat estimates, driven by demand for AI infrastructure. Cisco now trades as a premium, moderately growing tech company.
Novo Nordisk (NVO) Stock Today: Worst Year on Record, Fresh Downgrades – and a New 2026 Forecast (11 December 2025)

Novo Nordisk (NVO) Stock Today: Worst Year on Record, Fresh Downgrades – and a New 2026 Forecast (11 December 2025)

Novo Nordisk’s Copenhagen shares are down nearly 50% in 2025, heading for their worst year on record. U.S. ADRs trade near $49 after a recent rebound. SEB now forecasts organic sales will fall in 2026, citing U.S. price cuts and pressure on Ozempic. Seeking Alpha downgraded the stock, pointing to structural challenges and slowing revenue growth.
Dow Inc. (DOW) Stock Forecast and News Today: Dividend Reset, Legal Risks and 2026 Recovery Hopes

Dow Inc. (DOW) Stock Forecast and News Today: Dividend Reset, Legal Risks and 2026 Recovery Hopes

Dow Inc. shares closed at $24.59 on December 10 after a two-day rally but remain over 40% below last year’s high. Year-to-date, the stock is down about 42% amid weak chemical prices, oversupply, and a July dividend cut to $0.35 per quarter. Q3 results showed a smaller-than-expected loss but revenue and margins lag 2024. Analysts mostly rate the stock “Hold” with modest upside.
11 December 2025
Microsoft Stock (MSFT) on December 11, 2025: AI Bubble Fears, $23 Billion Bets and Conflicting Price Targets

Microsoft Stock (MSFT) on December 11, 2025: AI Bubble Fears, $23 Billion Bets and Conflicting Price Targets

Microsoft shares closed at $478.56 on December 10, down 2.7%, and traded around $474–475 premarket December 11. The drop followed Oracle’s weak forecast and AI spending concerns, which pressured tech stocks. Microsoft’s market cap stands near $3.5–3.9 trillion, with a trailing P/E in the mid-30s. U.S. state attorneys general also warned Microsoft and peers over risks from AI chatbots.
Uber Stock Slides as EV Incentives Fade and EU Risks Mount — Can Robotaxis and Profits Keep the Rally Alive?

Uber Stock Slides as EV Incentives Fade and EU Risks Mount — Can Robotaxis and Profits Keep the Rally Alive?

Uber shares fell 5.5% to $84.16 on December 10, trading on heavy volume after the company scaled back electric vehicle incentives and backed U.S. legislation rolling back clean-energy support. Despite the drop, Uber stock remains up nearly 48% for 2025. Wall Street’s average 12-month price target stands at $108.94, according to StockAnalysis.
Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics shares surged 45% to $37.35 on December 11, 2025, after fiscal Q4 results beat expectations and guidance topped forecasts. Q4 revenue reached about $216 million, up 3% sequentially and above analyst estimates. Non-GAAP EPS was $0.60, roughly 33% above consensus. The stock now trades above all major analyst price targets.
Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

Oracle shares plunged over 12% Thursday after the company missed revenue estimates and warned of higher AI-related spending, fueling concerns about an “AI bubble.” U.S. stock futures fell, with S&P 500 and Nasdaq 100 contracts down as much as 1.2%. The selloff followed the Federal Reserve’s third straight rate cut, which failed to lift markets. Several micro-cap stocks also posted sharp losses.
U.S. Stock Market Today, December 11, 2025: Dow, S&P 500 and Nasdaq Slip as Oracle Revives AI Bubble Fears After Fed Rate Cut

U.S. Stock Market Today, December 11, 2025: Dow, S&P 500 and Nasdaq Slip as Oracle Revives AI Bubble Fears After Fed Rate Cut

U.S. stock index futures fell early Thursday, with S&P 500 futures down 0.6% and Nasdaq 100 futures off 0.8% as investors reacted to Oracle’s weak earnings and renewed AI bubble concerns. This follows a Wednesday rally that pushed the S&P 500 within five points of a record after the Federal Reserve cut rates for the third time in 2025.
Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025)

Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025)

The Federal Reserve cut its benchmark rate by 25 basis points to 3.50%–3.75% on December 10, its third reduction this year. Trading volume surged in micro-cap stocks like HeartBeam and Agape ATP, as well as tech giants Nvidia and Tesla. U.S. futures pointed lower amid renewed AI-bubble fears after Oracle’s earnings and a $15 billion AI investment. Momentum from Wednesday’s session carried into Thursday.
11 December 2025

Stock Market Today

  • Nvidia: The 'Magnificent Seven' Stock Offering a Rare Buying Opportunity
    June 29, 2026, 5:30 AM EDT. The 'Magnificent Seven' tech stocks-Amazon, Apple, Alphabet, Microsoft, Meta Platforms, Nvidia, and Tesla-have propelled the AI market boom but recently saw valuations decline amid economic concerns. Nvidia stands out as a once-in-a-decade buying opportunity, now trading at a forward price-to-earnings ratio of 21, down from over 48 last year. Despite the dip, Nvidia reported over $215 billion in annual revenue, reflecting strong demand for its AI-related products. Analysts view the current valuation as a bargain given the robust AI growth story and recent earnings momentum, suggesting potential upside as investor confidence returns.

Latest articles

Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

29 June 2026
Microsoft surged 5.7% to $372.97 in premarket trading, adding $149 billion in market value, as investors weigh soaring AI-driven capex—Q3 spending was about twice free cash flow—against strong cloud growth and a $37 billion AI revenue run rate, while analysts warn higher costs could pressure margins.
Apple shares hold steady as buyback talk meets AI chip strain

Apple shares hold steady as buyback talk meets AI chip strain

29 June 2026
Apple surged 3.14% Friday with trading volume at 506% of its 65-day average as investors weigh a $100 billion buyback—potentially reducing shares by 2.4%—against soaring memory costs and Apple’s push for U.S. approval to buy DRAM from blacklisted CXMT, raising policy risks as device price hikes hit Macs and iPads.
Go toTop